Literature DB >> 9693214

Hepatic fibrosis - therapeutic strategies.

D Schuppan1, D Strobel, E G Hahn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9693214     DOI: 10.1159/000007494

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


× No keyword cloud information.
  5 in total

1.  Relationship between transforming growth factor beta1 and anti-fibrotic effect of interleukin-10.

Authors:  Mei-Na Shi; Yue-Hong Huang; Wei-Da Zheng; Li-Juan Zhang; Zhi-Xin Chen; Xiao-Zhong Wang
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

Review 2.  TGFbeta-induced fibrogenesis of the pancreas.

Authors:  Andre Menke; Guido Adler
Journal:  Int J Gastrointest Cancer       Date:  2002

3.  Effect of IL-10 on the expression of HSC growth factors in hepatic fibrosis rat.

Authors:  Mei-Na Shi; Wei-Da Zheng; Li-Juan Zhang; Zhi-Xin Chen; Xiao-Zhong Wang
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

4.  Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis.

Authors:  C Raetsch; J D Jia; G Boigk; M Bauer; E G Hahn; E-O Riecken; D Schuppan
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

5.  Serum collagen type VI and XIV and hyaluronic acid as early indicators for altered connective tissue turnover in alcoholic liver disease.

Authors:  F Stickel; R Urbaschek; D Schuppan; G Poeschl; C Oesterling; C Conradt; R S McCuskey; U A Simanowski; H K Seitz
Journal:  Dig Dis Sci       Date:  2001-09       Impact factor: 3.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.